Product Information
FLUOXETINE HCL 10 MG CAPSULE is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0353 per EA under NDC 50228011310. Its NADAC has been published 380 times since Jun 26, 2019.
FDA first approved this application on Mar 16, 2015. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228011310
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204597FDA Approved
3/16/2015
TE Code
AB1
On Market Since
3/16/2015
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 10 MG CAPSULE has been published 380 times since Jun 26, 2019, and over the history we have for it it has declined 4.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0353 per EA |
|---|---|
| All-time high | $0.0390 (Mar 10, 2021) |
| All-time low | $0.0283 (Nov 20, 2024) |
| 52-week high | $0.0371 |
| 52-week low | $0.0315 |
| Median price | $0.0348 |
| Average price | $0.0349 |
| Largest weekly change | -17.2% (Nov 20, 2024) |
| Weeks tracked | 380 |
| Tracking since | Jun 26, 2019 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ScieGen Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluoxetine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 10 MG CAPSULE, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0353 per EA (NDC 50228011310), effective Sep 30, 2026.
How has the price of FLUOXETINE HCL 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 10 MG CAPSULE has declined 4.0%. It has been tracked across 380 weekly CMS publications since Jun 26, 2019.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 10 MG CAPSULE?
Since Jun 26, 2019, the NADAC for FLUOXETINE HCL 10 MG CAPSULE has ranged from a low of $0.0283 (Nov 20, 2024) to a high of $0.0390 (Mar 10, 2021), with a median of $0.0348 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 10 MG CAPSULE?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUOXETINE HCL 10 MG CAPSULE, is $0.0341 per EA — about 3% below FLUOXETINE HCL 10 MG CAPSULE.
Who manufactures FLUOXETINE HCL 10 MG CAPSULE?
FLUOXETINE HCL 10 MG CAPSULE (NDC 50228011310) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.